Immunocore Holdings Plc (IMCR)
30.41
+0.26
(+0.86%)
USD |
NASDAQ |
Apr 01, 14:32
Immunocore Holdings EPS Diluted (Quarterly) : -0.5948 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -0.0795 |
| Haleon Plc | -- |
| Silence Therapeutics Plc | -0.0831 |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.02M |
| Revenue (Quarterly) | 104.33M |
| Total Expenses (Quarterly) | 134.34M |
| Enterprise Value | 1.101B |
| Gross Profit Margin (Quarterly) | 96.61% |
| Profit Margin (Quarterly) | -28.77% |
| Earnings Yield | -2.33% |
| Normalized Earnings Yield | -3.224 |